Disruptive Behavior Disorder (DBD) Medication Market Outlook, 2018–2026

Disruptive behavior disorder comprises a group of disorders including oppositional defiant disorder, conduct disorder, and intermittent explosive disorder. It usually affects young people below 18 years of age. Children/teenagers suffering from this disorder are unable to regulate her/his emotions and behaviors, act defiant, and are in conflict with other peers in surrounding thereby facing low quality of life at home, school, or both. Various causes of DBD include child abuse or neglect, a traumatic life experience, such as sexual abuse or violence, and a family history of DBDs. DBDs can be treated with variety of option, initiated with psychological therapy. Under psychological therapy, counselling and guidance is provided either to parent or child alone, or family together, to improve response to incidence of DBDs. Medication treatment is preferred either in combination with psychological treatment or started when psychological therapy proves to be insufficient.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2390

Disruptive Behavior Disorder Medication Market - Market Dynamics

Major factors responsible for growth of the disruptive behavior disorder medication market are rising burden of the disruptive behavior disorders worldwide, increasing awareness amongst parent about this disorder, and improvement of psychotic and medication treatment. According to a study published in the journal BMJ Open (Matthew D Burkey et al) in 2015, oppositional defiant disorder (ODD) and conduct disorder (CD) had an estimated worldwide prevalence of 3.3% and 3.2%, respectively. World Health Organization in its 2016 factsheet stated that globally, 7.4 % of disability-adjusted life years (DALYs) are caused by disorders in mental and behavioral disorders category.

Disruptive Behavior Disorder Medication Market - Regional Insights

On the basis of geography, disruptive behavior disorder medication market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the leading region in the disruptive behavior disorder medication market during forecast period. According to statistics given by Agency for Healthcare Research and Quality in 2016, 3 out of every 100 children in the U.S. are affected by disruptive behavior disorder, it affects more number of boys than girls and is common among children aged 12 years and older. ‘Speak Up for Kids’ campaign is an education and outreach initiatives by Child Mind Institute (U.S. based non-profit organization), through which awareness about mental health issues and needed information is provided to families, educators, the media, and policymakers. Various medical centers and hospitals such as Arkansas Valley Behavioral Health System have established dedicated resources for treatment of disruptive behavior disorder.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2390

Disruptive Behavior Disorder Medication Market - Competitive Landscape

Key players present in the disruptive behavior disorder medication market are Promius Pharma LLC, Shire PLC, Johnson and Johnson, Mylan N.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Lupin Ltd., and Eli Lilly and Company.

Disruptive Behavior Disorder Medication Market - Market Taxonomy

On the basis of disease type, the global disruptive behavior disorder medication market is segmented into: Oppositional Defiant Disorder, Conduct Disorder, Intermittent Explosive Disorder,.

On the basis of drug class, the global disruptive behavior disorder medication market is segmented into: Stimulant, Antipsychotics, Alpha Agonist, Anticonvulsant, Others,. On the basis of drug class, the global disruptive behavior disorder medication market is segmented into: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy,. On the basis of geography, the disruptive behavior disorder medication market is segmented into: North America, Latin America, Europe, Asia Pacific,Middle East, Africa,.

Browse Full Report: https://www.coherentmarketinsights.com/ongoing-insight/disruptive-behavior-disorder-dbd-medication-market-2390

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

Contact US: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel : +1-206-701-6702 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com